Lynn Kirkpatrick
2022
In 2022, Lynn Kirkpatrick earned a total compensation of $622.6K as Chief Executive Officer at Ensysce Biosciences, a 116% increase compared to previous year.
Compensation breakdown
| Option Awards | $214,914 |
|---|---|
| Salary | $392,500 |
| Other | $15,195 |
| Total | $622,609 |
Kirkpatrick received $392.5K in salary, accounting for 63% of the total pay in 2022.
Kirkpatrick also received $214.9K in option awards and $15.2K in other compensation.
Rankings
In 2022, Lynn Kirkpatrick's compensation ranked 3,984th out of 5,717 executives tracked by ExecPay. In other words, Kirkpatrick earned more than 30.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,984 out of 5,717 | 30th |
Division Manufacturing | 2,252 out of 3,111 | 28th |
Major group Chemicals And Allied Products | 1,088 out of 1,410 | 23rd |
Industry group Drugs | 1,021 out of 1,311 | 22nd |
Industry Pharmaceutical Preparations | 745 out of 957 | 22nd |
Source: SEC filing on July 13, 2023.
Kirkpatrick's colleagues
We found three more compensation records of executives who worked with Lynn Kirkpatrick at Ensysce Biosciences in 2022.
News
Ensysce Biosciences CEO Lynn Kirkpatrick's 2023 pay slips 18% to $509K
October 17, 2024
Ensysce Biosciences CFO David Humphrey's 2022 pay jumps 175% to $781K
July 13, 2023
Ensysce Biosciences CEO Lynn Kirkpatrick's 2021 pay jumps 85% to $288K
May 2, 2022
Ensysce Biosciences CEO D Kirkpatrick receives $156K in 2020
December 17, 2021